Publication | Open Access

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Platinum-based TherapyUrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicineDocetaxel Versus PlaceboClinical TrialsImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncology